TrialPloS one2012

T cell vaccination benefits relapsing progressive multiple sclerosis patients: a randomized, double-blind clinical trial.

Dimitrios Karussis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.